Your search returned 12 results.

Results
	1.	Bile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat. [electronic resource] by Suttle, A B Brouwer, K L Producer: 19940726 In: Drug metabolism and disposition: the biological fate of chemicals vol. 22 Availability: No items available. Save to lists Add to cart (remove)
	2.	Gastrointestinal transit and distribution of ranitidine in the rat. [electronic resource] by Suttle, A B Brouwer, K L Producer: 19960305 In: Pharmaceutical research vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Regional gastrointestinal absorption of ranitidine in the rat. [electronic resource] by Suttle, A B Brouwer, K L Producer: 19960305 In: Pharmaceutical research vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles. [electronic resource] by Suttle, A B Pollack, G M Brouwer, K L Producer: 19920724 In: Pharmaceutical research vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Preclinical Modeling of Tumor Growth and Angiogenesis Inhibition to Describe Pazopanib Clinical Effects in Renal Cell Carcinoma. [electronic resource] by Ouerdani, A Struemper, H Suttle, A B Ouellet, D Ribba, B Producer: 20160119 In: CPT: pharmacometrics & systems pharmacology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Ranitidine does not alter adinazolam pharmacokinetics or pharmacodynamics. [electronic resource] by Suttle, A B Songer, S S Dukes, G E Hak, L J Koruda, M Fleishaker, J C Brouwer, K L Producer: 19921022 In: Journal of clinical psychopharmacology vol. 12 Availability: No items available. Save to lists Add to cart (remove)
	7.	Comparison of zafirlukast (Accolate) absorption after oral and colonic administration in humans. [electronic resource] by Fischer, J D Song, M H Suttle, A B Heizer, W D Burns, C B Vargo, D L Brouwer, K L Producer: 20000605 In: Pharmaceutical research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma. [electronic resource] by Suttle, A B Ball, H A Molimard, M Hutson, T E Carpenter, C Rajagopalan, D Lin, Y Swann, S Amado, R Pandite, L Producer: 20150120 In: British journal of cancer vol. 111 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies. [electronic resource] by Tan, A R Dowlati, A Stein, M N Jones, S F Infante, J R Bendell, J Kane, M P Levinson, K T Suttle, A B Burris, H A Producer: 20140714 In: British journal of cancer vol. 110 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	A phase I study of the pharmacokinetic and safety profiles of oral pazopanib with a high-fat or low-fat meal in patients with advanced solid tumors. [electronic resource] by Heath, E I Chiorean, E G Sweeney, C J Hodge, J P Lager, J J Forman, K Malburg, L Arumugham, T Dar, M M Suttle, A B Gainer, S D LoRusso, P Producer: 20101214 In: Clinical pharmacology and therapeutics vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I study. [electronic resource] by Hamberg, P Boers-Sonderen, M J van der Graaf, W T A de Bruijn, P Suttle, A B Eskens, F A L M Verweij, J van Herpen, C M L Sleijfer, S Producer: 20140415 In: British journal of cancer vol. 110 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	An evaluation of the drug interaction potential of pazopanib, an oral vascular endothelial growth factor receptor tyrosine kinase inhibitor, using a modified Cooperstown 5+1 cocktail in patients with advanced solid tumors. [electronic resource] by Goh, B C Reddy, N J Dandamudi, U B Laubscher, K H Peckham, T Hodge, J P Suttle, A B Arumugham, T Xu, Y Xu, C-F Lager, J Dar, M M Lewis, L D Producer: 20101108 In: Clinical pharmacology and therapeutics vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)